ATHA

Athira Pharma, Inc.

2.79
USD
-2.11%
2.79
USD
-2.11%
2.53 16.65
52 weeks
52 weeks

Mkt Cap 104.21M

Shares Out 37.35M

Chat
Send me real-time posts from this site at my email

Health Care Sector Update for 04/20/2022: ALVR,ANTM,ATHA

Health care stocks were higher this afternoon, with the NYSE Health Care Index rising 1.5% while the SPDR Health Care Select Sector ETF (XLV) was up 1.6%. The Nasdaq Biotechnology index was climbing 0.8%. In company news, AlloVir (ALVR) was gaining almost 29% after the US Food and Drug Administration designated the company's posoleucel T-cell therapy as an regenerative medicine advanced therapy. Anthem (ANTM) added 2.4% after reporting adjusted Q1 earnings and revenue that exceeded Wall Street expectations and raised its FY22 earnings outlook. Athira Pharma (ATHA) rose 1% after the drug maker called on its shareholders to support its three director candidates and reject a bid by activist shareholder Richard Kayne. Kayne recently nominated himself and former Novartis Pharma chief financial officer George Bickerstaff III for election to the board this year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue